← All trials
NCT05901779
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2023
- Primary completion
- Mar 1, 2024
- Completion date
- May 1, 2024
- First posted
- Jun 13, 2023
- Last posted
- Jun 13, 2023
- Enrollment
- 318
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Qingdao UniversityLead sponsor
- Binzhou Medical UniversityCollaborator
- Binzhou Medical UniversityCollaborator
- Jinan UniversityCollaborator
- Jining NO.1 People 's HospitalCollaborator
- Liaocheng People's HospitalCollaborator
- Shandong Province Qianfoshan HospitalCollaborator
- Shandong UniversityCollaborator
- Qingdao Municipal HospitalCollaborator
- People's Hospital of RizhaoCollaborator
- Shandong UniversityCollaborator
- Shandong Provincial HospitalCollaborator
- Qingdao UniversityStudy director
- Shandong UniversityCollaborator
- Weifang Medical UniversityCollaborator
- Weifang People's HospitalCollaborator
- Weihai Central HospitalCollaborator
- Weihai Municipal HospitalCollaborator
- Qingdao UniversityCollaborator
- Qingdao UniversityOfficial
- The People's Hospital of Jimo.QingdaoCollaborator
- Dongying People's Hospital, ShandongCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.